PHARMACEUTICAL COMPOSITION FOR A HEPATITIS C VIRAL PROTEASE INHIBITOR

• 收藏
• 分享

专利权人:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

发明人:

CHEN, FENG-JING,SCHWABE,ROBERT J.

申请号：

MYPI 2012000028

公开号：

MY154683A

申请日:

2010.07.01

申请国别(地区):

MY

年份:

2015

代理人:

摘要：

DISCLOSED IS A PHARMACEUTICAL COMPOSITION OF A HEPATITIS C VIRAL PROTEASE INHIBITOR WHICH IS SUITABLE FOR ORAL ADMINISTRATION VIA A LIQUID- OR SEMI-SOLID-FILED CAPSULE AND METHODS OF USING THIS COMPOSITION FOR INHIBITING THE REPLICATION OF THE HEPATITIS C VIRUS (HCV) AND FOR THE TREATMENT OF AN HCV INFECTION. THE LIQUID- OR SEMI-SOLID PHARMACEUTICAL COMPOSITION OF THE PRESENT INVENTION COMPRISES A COMPOUND OF FORMULA 1, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, TOGETHER WITH ONE OR MORE PHARMACEUTICALLY ACCEPTABLE LIPIDS AND HYDROPHILIC SURFACTANTS.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/